These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2476997)

  • 1. A search for calcium-channel activators in the verapamil series.
    Romanelli MN; Gualtieri F; Mannhold R; Chiarini A
    Farmaco; 1989 May; 44(5):449-64. PubMed ID: 2476997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.
    Vo D; Matowe WC; Ramesh M; Iqbal N; Wolowyk MW; Howlett SE; Knaus EE
    J Med Chem; 1995 Jul; 38(15):2851-9. PubMed ID: 7543577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The design of (-)-(S)-2-nitrooxyethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl) pyridine-5-carboxylate: a cardioselective positive inotropic derivative of Bay K 8644.
    Shan R; Knaus EE
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2613-4. PubMed ID: 10498219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and synthesis of methyl 2,5-dimethyl-4-[2- (phenylmethyl)benzoyl]-1H-pyrrole-3-carboxylate (FPL 64176) and analogues: the first examples of a new class of calcium channel activator.
    Baxter AJ; Dixon J; Ince F; Manners CN; Teague SJ
    J Med Chem; 1993 Sep; 36(19):2739-44. PubMed ID: 7692047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the novel calcium channel blocker, anipamil, on the isolated rabbit heart. Comparison with verapamil and gallopamil.
    Raddino R; Poli E; Pasini E; Ferrari R
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):339-44. PubMed ID: 1383837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and cardiovascular properties of fluorenyl derivatives related to verapamil.
    Romanelli MN; Teodori E; Scapecchi S; Dei S; Budriesi R; Chiarini A
    Farmaco; 1991 Oct; 46(10):1121-38. PubMed ID: 1815578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of caffeine on contractions and calcium movement in vascular and intestinal smooth muscle.
    Ahn HY; Karaki H; Urakawa N
    Br J Pharmacol; 1988 Feb; 93(2):267-74. PubMed ID: 2451962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist of dihydropyridine receptors, BayK8644 depresses excitation-contraction coupling in myocytes of guinea pig heart.
    Mackiewicz U; Emanuel K; Lewartowski B
    J Physiol Pharmacol; 2001 Sep; 52(3):459-69. PubMed ID: 11596863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.
    Ishii K; Taira N; Yanagisawa T
    Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of felodipine, nifedipine and verapamil on cytosolic Ca2+ and contraction in vascular smooth muscle.
    Hagiwara S; Mitsui M; Karaki H
    Eur J Pharmacol; 1993 Mar; 234(1):1-7. PubMed ID: 7682512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Ca2+ channel agonists and antagonists on the post-rest staircase.
    Harrison S; Milner R; Boyett M
    Eur J Pharmacol; 1993 Jun; 237(1):83-92. PubMed ID: 7689472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
    Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
    Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-rigid analogues of the calcium antagonist verapamil: a molecular modelling study.
    Romanelli MN; Dei S; Scapecchi S; Teodori E; Gualtieri F; Budriesi R; Mannhold R
    J Comput Aided Mol Des; 1994 Apr; 8(2):123-34. PubMed ID: 8064330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel blocker-like action of reserpine in smooth muscle.
    Satoh T; Moriyama T; Kuriki H; Karaki H
    Jpn J Pharmacol; 1992 Nov; 60(3):291-3. PubMed ID: 1283423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the calcium channel facilitator, CGP 28,392, on different modes of contraction in smooth muscle of rabbit and rat aortae and guinea-pig taenia caeci.
    Karaki H; Nagase H; Ozaki H; Urakawa N; Weiss GB
    Br J Pharmacol; 1986 Oct; 89(2):423-9. PubMed ID: 3779218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thaliporphine, a positive inotropic agent with a negative chronotropic action.
    Su MJ; Chang YM; Chi JF; Lee SS
    Eur J Pharmacol; 1994 Mar; 254(1-2):141-50. PubMed ID: 7515818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological dissection of Ca2+ channels in the rat aorta by Ca2+ entry modulators.
    Rico I; Alonso MJ; Salaices M; Marín J
    Pharmacology; 1990; 40(6):330-42. PubMed ID: 1700444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cardiotonic sodium channel activators by potassium depolarization in isolated guinea-pig atria.
    Berthold H; Scholtysik G; Schaad A
    J Pharmacol Methods; 1990 Sep; 24(2):121-35. PubMed ID: 1700227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RS 30026: a potent and effective calcium channel agonist.
    Patmore L; Duncan GP; Clarke B; Anderson AJ; Greenhouse R; Pfister JR
    Br J Pharmacol; 1990 Apr; 99(4):687-94. PubMed ID: 1694461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
    Nishimura K; Miyawaki N; Yamauchi H; Iso T
    Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.